Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Core One Labs Inc C.COOL

Alternate Symbol(s):  CLABF

Core One Labs Inc. is a Canada-based life sciences biotechnology research and development company. The Company is focused on bringing psychedelic medicines to market through the development and production of psychedelic compounds, the advancement of psychedelic assisted treatments, and the integration of delivery systems technology. Its subsidiary, Vocan Biotechnologies Inc., has developed and filed for patent protection of a proprietary psilocybin production system using engineered bacteria. It is also the holder of four provisional patents for the development of psychedelic-based pharmaceutical formulations targeting neurological and mental health disorders, under its subsidiary Akome Biotech Ltd., and three provisional patents under its other subsidiary, Awakened Biosciences Inc., for additional synthetic technologies for psilocybin and psilocin production methods. It also holds an interest in four medical clinics, which maintain a combined database of more than 275,000 patients.


CSE:COOL - Post by User

Bullboard Posts
Comment by Straniuson Apr 25, 2017 6:43pm
226 Views
Post# 26165430

RE:RE:RE:Boy it's taking long for Canacrap to do their dd

RE:RE:RE:Boy it's taking long for Canacrap to do their ddA bit of both. I was privi to a datapoint to suggest this was the case last week. The price action this week corroborates what I stated in my earlier post.

Having said the above... it would not be the end of the world to close at less than full other than spook some investors. It would cause less dilution at 50 cents and give the company enough growth capital and an opportunity to raise more capital in the future (if needed) at a higher prices and less dilution to existing shareholders. 

~S

fruiscante1 wrote: Source? Or just taking a guess?

Thanks


Bullboard Posts